Guidance for Organ Donation and Transplantation Professionals Regarding the Zika Virus
Published 4 February 2016
UNOS; Feb 2016.

Zika virus is a flavivirus transmitted by Aedes (Stegomyia) mosquitoes, most commonly by A. aegypti. Zika virus has been recognized in Brazil since 2014, and local transmission now has been reported in more than 20 countries and territories in the Western Hemisphere, including South America, Central America, Mexico, and the Caribbean.
The OPTN/UNOS Ad Hoc Disease Transmission Advisory Committee (DTAC), the American Society of Transplantation (AST), and the American Society of Transplant Surgeons (ASTS), after careful review of information available from the Centers for Disease Control and Prevention (CDC), offers this information to transplant centers and Organ Procurement Organizations (OPOs) in light of recent spread of Zika virus throughout large parts of the Americas.
Read at UNOSRelated Guidlines
-
Utilization of Hepatitis C Virus–Infected Organ Donors in Cardiothoracic Transplantation
-
Consensus Statements from the ISHLT Consensus Conference: Heart Failure Related Cardiogenic Shock
-
Test: Impact of Preoperative Temporary Mechanical Circulatory Support on Durable LVAD Outcomes An Analysis of The Society of Thoracic Surgeons National Intermacs Database
-
Assessing and Addressing Frailty in Candidates for Lung Transplantation: An ISHLT Consensus Statement
-
Revision of the 1990 Working Formulation for the Standardization of Nomenclature in the Diagnosis of Heart Rejection

